Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3051
QuinStreet
QNST
$890M
| $603K | ﹤0.01% |
37,966
-8,832
| -19% | -$140K |
|
3052
Amerant Bancorp
AMTB
$1.16B
| $602K | ﹤0.01% |
27,657
+11,506
| +71% | +$306K |
|
|
VLD
3053
DELISTED
Velo3D, Inc.
VLD
| $601K | ﹤0.01% |
7,567
-660
| -8% | -$59.3K |
|
|
NVEI
3054
DELISTED
Nuvei Corporation Subordinate Voting Shares
NVEI
| $601K | ﹤0.01% |
13,798
-797,446
| -98% | -$27.8M |
|
3055
Compass Diversified
CODI
$795M
| $600K | ﹤0.01% |
31,457
+1,695
| +6% | +$34.7K |
|
3056
Tactile Systems Technology
TCMD
$635M
| $598K | ﹤0.01% |
36,446
-8,106
| -18% | -$113K |
|
3057
HUTCHMED
HCM
$2.01B
| $598K | ﹤0.01% |
45,918
+35,883
| +358% | +$588K |
|
3058
Vanguard FTSE All-World ex-US ETF
VEU
$66.9B
| $595K | ﹤0.01% |
11,135
| – | – |
|
3059
Rocket Lab Corp
RKLB
$44B
| $594K | ﹤0.01% |
147,152
-230,404
| -61% | -$1.03M |
|
3060
Mirion Technologies
MIR
$3.73B
| $594K | ﹤0.01% |
69,591
+32,806
| +89% | +$260K |
|
3061
ProShares Short VIX Short-Term Futures ETF
SVXY
$202M
| $593K | ﹤0.01% |
18,610
+12,800
| +220% | +$403K |
|
3062
ZipRecruiter
ZIP
$321M
| $593K | ﹤0.01% |
37,210
+11,981
| +47% | +$216K |
|
3063
TriMas Corp
TRS
$1.43B
| $593K | ﹤0.01% |
21,275
+10,028
| +89% | +$294K |
|
3064
Warby Parker
WRBY
$3.28B
| $592K | ﹤0.01% |
55,934
+29,135
| +109% | +$399K |
|
3065
Anika Therapeutics
ANIK
$277M
| $591K | ﹤0.01% |
20,568
-4,405
| -18% | -$131K |
|
|
LONA
3066
LeonaBio Inc
LONA
$70.2M
| $590K | ﹤0.01% |
23,612
+2,803
| +13% | +$90.3K |
|
3067
CryoPort
CYRX
$781M
| $587K | ﹤0.01% |
24,475
+12,607
| +106% | +$274K |
|
3068
PUT
Chevron
CVX
$385B
| $587K | ﹤0.01% |
3,600
+2,800
| +350% | +$469K |
|
3069
PUT
Academy Sports + Outdoors
ASO
$3.01B
| $587K | ﹤0.01% |
9,000
-419,100
| -98% | -$24.7M |
|
3070
Buckle
BKE
$2.37B
| $587K | ﹤0.01% |
16,449
-22,263
| -58% | -$912K |
|
3071
Protolabs
PRLB
$1.79B
| $587K | ﹤0.01% |
17,695
+4,486
| +34% | +$139K |
|
3072
LSB Industries
LXU
$783M
| $586K | ﹤0.01% |
56,773
+20,653
| +57% | +$252K |
|
|
VTYX
3073
DELISTED
Ventyx Biosciences
VTYX
| $586K | ﹤0.01% |
17,504
+6,669
| +62% | +$259K |
|
3074
Build-A-Bear
BBW
$424M
| $585K | ﹤0.01% |
25,193
+21,562
| +594% | +$501K |
|
|
CCRN
3075
DELISTED
Cross Country Healthcare
CCRN
| $585K | ﹤0.01% |
26,213
+1,756
| +7% | +$46K |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.